$36.89
5.31% yesterday
Nasdaq, Nov 15, 10:08 pm CET
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Twist Bioscience Corp. Stock price

$36.89
-9.42 20.34% 1M
-11.47 23.72% 6M
+0.03 0.08% YTD
+16.99 85.38% 1Y
-74.18 66.79% 3Y
+15.03 68.76% 5Y
+22.89 163.50% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-2.07 5.31%
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Key metrics

Market capitalization $2.16b
Enterprise Value $1.96b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.64
P/S ratio (TTM) P/S ratio 7.32
P/B ratio (TTM) P/B ratio 4.40
Revenue growth (TTM) Revenue growth 25.37%
Revenue (TTM) Revenue $295.21m
EBIT (operating result TTM) EBIT $-186.47m
Free Cash Flow (TTM) Free Cash Flow $-74.95m
Cash position $289.42m
EPS (TTM) EPS $-3.81
P/E forward negative
P/S forward 7.34
EV/Sales forward 6.69
Short interest 20.10%
Show more

Is Twist Bioscience Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Twist Bioscience Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Twist Bioscience Corp. forecast:

9x Buy
75%
2x Hold
17%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Twist Bioscience Corp. forecast:

Buy
75%
Hold
17%
Sell
8%

Financial data from Twist Bioscience Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
295 295
25% 25%
100%
- Direct Costs 176 176
21% 21%
59%
120 120
32% 32%
41%
- Selling and Administrative Expenses 179 179
18% 18%
61%
- Research and Development Expense 93 93
17% 17%
32%
-153 -153
12% 12%
-52%
- Depreciation and Amortization 33 33
25% 25%
11%
EBIT (Operating Income) EBIT -186 -186
15% 15%
-63%
Net Profit -220 -220
5% 5%
-75%

In millions USD.

Don't miss a Thing! We will send you all news about Twist Bioscience Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Twist Bioscience Corp. Stock News

Neutral
Business Wire
one day ago
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the 7th Annual Evercore He...
Positive
Seeking Alpha
8 days ago
Since I last covered it, Twist Bioscience has made significant strides. They have secured new partnerships, launched innovative products, and secured strategic financial agreements. TWST's valuation multiples now appear more reasonable, making it a compelling buy for new investors, with a long cash runway and potential self-sustainability by 2025-2026. The company has improved its gross margins...
Neutral
Business Wire
17 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the FlexPrep™ Ultra-High Throughput Library Preparation Kit, designed with a proprietary Twist-developed enzyme to enable throughput at a low cost, and accel...
More Twist Bioscience Corp. News

Company Profile

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Head office United States
CEO Emily Leproust
Employees 919
Founded 2013
Website www.twistbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today